298 related articles for article (PubMed ID: 20302875)
1. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling.
Kirchhefer U; Wehrmeister D; Postma AV; Pohlentz G; Mormann M; Kucerova D; Müller FU; Schmitz W; Schulze-Bahr E; Wilde AA; Neumann J
J Mol Cell Cardiol; 2010 Jul; 49(1):95-105. PubMed ID: 20302875
[TBL] [Abstract][Full Text] [Related]
2. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
Kontula K; Laitinen PJ; Lehtonen A; Toivonen L; Viitasalo M; Swan H
Cardiovasc Res; 2005 Aug; 67(3):379-87. PubMed ID: 15913575
[TBL] [Abstract][Full Text] [Related]
3. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.
Song L; Alcalai R; Arad M; Wolf CM; Toka O; Conner DA; Berul CI; Eldar M; Seidman CE; Seidman JG
J Clin Invest; 2007 Jul; 117(7):1814-23. PubMed ID: 17607358
[TBL] [Abstract][Full Text] [Related]
4. Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
Chopra N; Kannankeril PJ; Yang T; Hlaing T; Holinstat I; Ettensohn K; Pfeifer K; Akin B; Jones LR; Franzini-Armstrong C; Knollmann BC
Circ Res; 2007 Sep; 101(6):617-26. PubMed ID: 17656677
[TBL] [Abstract][Full Text] [Related]
5. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.
Viatchenko-Karpinski S; Terentyev D; Györke I; Terentyeva R; Volpe P; Priori SG; Napolitano C; Nori A; Williams SC; Györke S
Circ Res; 2004 Mar; 94(4):471-7. PubMed ID: 14715535
[TBL] [Abstract][Full Text] [Related]
6. Sarcoplasmic reticulum Ca2+ release in neonatal rat cardiac myocytes.
Gergs U; Kirchhefer U; Buskase J; Kiele-Dunsche K; Buchwalow IB; Jones LR; Schmitz W; Traub O; Neumann J
J Mol Cell Cardiol; 2011 Nov; 51(5):682-8. PubMed ID: 21871897
[TBL] [Abstract][Full Text] [Related]
7. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.
Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S
Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229
[TBL] [Abstract][Full Text] [Related]
8. Ryanodine receptor and calsequestrin in arrhythmogenesis: what we have learnt from genetic diseases and transgenic mice.
Liu N; Rizzi N; Boveri L; Priori SG
J Mol Cell Cardiol; 2009 Feb; 46(2):149-59. PubMed ID: 19027025
[TBL] [Abstract][Full Text] [Related]
9. Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.
Alcalai R; Wakimoto H; Arad M; Planer D; Konno T; Wang L; Seidman JG; Seidman CE; Berul CI
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):316-24. PubMed ID: 20807279
[TBL] [Abstract][Full Text] [Related]
10. Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.
Kalyanasundaram A; Viatchenko-Karpinski S; Belevych AE; Lacombe VA; Hwang HS; Knollmann BC; Gyorke S; Periasamy M
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H253-61. PubMed ID: 21984545
[TBL] [Abstract][Full Text] [Related]
11. Modulation of SR Ca2+ release by the triadin-to-calsequestrin ratio in ventricular myocytes.
Kučerová D; Baba HA; Bokník P; Fabritz L; Heinick A; Mát'uš M; Müller FU; Neumann J; Schmitz W; Kirchhefer U
Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2008-17. PubMed ID: 22427521
[TBL] [Abstract][Full Text] [Related]
12. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
George CH; Higgs GV; Lai FA
Circ Res; 2003 Sep; 93(6):531-40. PubMed ID: 12919952
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of abnormal calcium homeostasis in mutations responsible for catecholaminergic polymorphic ventricular tachycardia.
Iyer V; Hajjar RJ; Armoundas AA
Circ Res; 2007 Feb; 100(2):e22-31. PubMed ID: 17234962
[TBL] [Abstract][Full Text] [Related]
14. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease.
Györke S; Terentyev D
Cardiovasc Res; 2008 Jan; 77(2):245-55. PubMed ID: 18006456
[TBL] [Abstract][Full Text] [Related]
15. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond.
Katz G; Arad M; Eldar M
Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246
[TBL] [Abstract][Full Text] [Related]
16. Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists.
Kirchhefer U; Jones LR; Begrow F; Boknik P; Hein L; Lohse MJ; Riemann B; Schmitz W; Stypmann J; Neumann J
Cardiovasc Res; 2004 Apr; 62(1):122-34. PubMed ID: 15023559
[TBL] [Abstract][Full Text] [Related]
17. Effects of calsequestrin over-expression on excitation-contraction coupling in isolated rabbit cardiomyocytes.
Miller SL; Currie S; Loughrey CM; Kettlewell S; Seidler T; Reynolds DF; Hasenfuss G; Smith GL
Cardiovasc Res; 2005 Sep; 67(4):667-77. PubMed ID: 15913577
[TBL] [Abstract][Full Text] [Related]
18. Protein protein interactions between triadin and calsequestrin are involved in modulation of sarcoplasmic reticulum calcium release in cardiac myocytes.
Terentyev D; Viatchenko-Karpinski S; Vedamoorthyrao S; Oduru S; Györke I; Williams SC; Györke S
J Physiol; 2007 Aug; 583(Pt 1):71-80. PubMed ID: 17569730
[TBL] [Abstract][Full Text] [Related]
19. Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells.
Kasneci A; Kemeny-Suss NM; Komarova SV; Chalifour LE
Cardiovasc Res; 2009 Mar; 81(4):695-702. PubMed ID: 19103607
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of junctin causes adaptive changes in cardiac myocyte Ca(2+) signaling.
Kirchhefer U; Hanske G; Jones LR; Justus I; Kaestner L; Lipp P; Schmitz W; Neumann J
Cell Calcium; 2006 Feb; 39(2):131-42. PubMed ID: 16289269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
